Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
AbbVie financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$189.4
2024-10-29
Market Capitalization
$335 B
2024-10-29
Revenue
$56.3 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 17, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| Revenue | 56.2B | 58.1B | 54.3B | 56.3B |
| Revenue growth, % | 22.7% | |||
| Cost of goods sold | 17.4B | 17.4B | 20.4B | 16.9B |
| Gross profit | 38.8B | 40.6B | 33.9B | 39.4B |
| Gross profit margin, % | 69.0% | 70.0% | 62.4% | 70.0% |
| General and administrative expense | 12.3B | 15.3B | 12.9B | 14.8B |
| Operating expense total | 20.8B | 22.5B | 21.1B | 30.3B |
| EBIT | 17.9B | 18.1B | 12.8B | 9.1B |
| EBIT margin, % | 31.9% | 31.2% | 23.5% | 16.2% |
| Investment income | 648.0M | |||
| Interest income | 648.0M | |||
| Interest expense | 2.4B | 2.0B | 1.7B | 2.8B |
| Pre tax profit | 13.0B | 13.5B | 6.3B | 3.7B |
| Income tax expense | 1.4B | 1.6B | 1.4B | (570.0M) |
| Net Income | 11.5B | 11.8B | 4.9B | 4.3B |
| EPS | 6.5 | 6.6 | 2.7 | 2.4 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |